This competitive renewal will continue an investigation of the effects of simulated ischemia and reperfusion on isolated adult ventricular cardiomyocytes. In addition, it will investigate myocytes from ventricular muscle subjected to ischemia and reperfusion in vivo. Because there is a wealth of data on in vivo myocardial ischemia and reperfusion in the dog, and because canine hearts and ventricular cardiomyocytes resemble those from humans, this competitive renewal will focus on canine ventricular cardiomyocytes. It will also investigate human ventricular cardiomyocytes when feasible. Three hypotheses will be tested: 1) That the mitochondrial inner membrane permeability transition, or """"""""pore"""""""" formation, is activated by simulated myocardial ischemia/reperfusion in isolated canine myocytes in vitro and by ischemia/reperfusion in vivo, and that the mitochondrial inner membrane permeability transition contributes to cell injury. Attempts will be made to inhibit the transition with cyclosporin A and other agents such as phospholipase inhibitors that work synergistically with cyclosporin A to preserve the mitochondrial inner membrane permeability barrier. Cyclosporin analogues, which unlike cyclosporin A do not inhibit calcineurin, yet still inhibit the inner membrane permeability transition, will be investigated as well; 2) That the ability of the sarcoplasmic reticulum to accumulate and release Ca2+ is altered by ischemia/reperfusion and that altered reactions of the sarcoplasmic reticulum contribute to post-ischemic contractile dysfunction. These studies will employ digitonin- permeabilized myocytes to assess the functional competence of the sarcoplasmic reticulum and to probe the status of the Ca2+ efflux pathways; 3) That ischemia/reperfusion produces alterations in the alpha and beta adrenergic receptors that have a negative impact on excitation- contraction coupling. These lead to post-ischemic contractile dysfunction and contribute to the development of ventricular arrhythmias. Receptor numbers and subtypes as well as second messenger production will be assessed in suspensions of intact canine myocytes. Effects on excitation- contraction coupling will be assessed in field stimulated single canine cells superfused with selected adrenergic agonists and antagonists. Excitation-contraction will be assessed with video-edge monitoring of cell length and fura-2 fluorescence microscopy to monitor intracellular free [Ca2+]. The above hypotheses focus on systems capable of influencing and being influenced by Ca2+ overload during ischemia and reperfusion. The resulting specific aims to test these hypotheses are logical extensions of work accomplished during the previous funding period.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Physical Biochemistry Study Section (PB)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ohio State University
Schools of Medicine
United States
Zip Code
Houle, M S; Altschuld, R A; Billman, G E (2001) Enhanced in vivo and in vitro contractile responses to beta(2)-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias. J Appl Physiol 91:1627-37
Altschuld, R A; Billman, G E (2000) beta(2)-Adrenoceptors and ventricular fibrillation. Pharmacol Ther 88:14-Jan
Carnes, C A; Mehdirad, A A (2000) Effects of azimilide, acidemia, and the combination on defibrillation energy requirements. J Cardiovasc Pharmacol 36:283-7
Mehdirad, A A; Carnes, C A; Nelson, S D (1999) The influence of specific and nonspecific potassium current blockade on the defibrillation energy requirement of biphasic shock. Pacing Clin Electrophysiol 22:147-51
Hohl, C M (1999) AMP deaminase in piglet cardiac myocytes: effect on nucleotide metabolism during ischemia. Am J Physiol 276:H1502-10
Carnes, C A; Mehdirad, A A; Nelson, S D (1998) Drug and defibrillator interactions. Pharmacotherapy 18:516-25
Matlib, M A; Zhou, Z; Knight, S et al. (1998) Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes. J Biol Chem 273:10223-31
Starling, R C; Hammer, D F; Altschuld, R A (1998) Human myocardial ATP content and in vivo contractile function. Mol Cell Biochem 180:171-7
Billman, G E; Castillo, L C; Hensley, J et al. (1997) Beta2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death. Circulation 96:1914-22
Hensley, J; Billman, G E; Johnson, J D et al. (1997) Effects of calcium channel antagonists on Ca2+ transients in rat and canine cardiomyocytes. J Mol Cell Cardiol 29:1037-43

Showing the most recent 10 out of 41 publications